KRAS and colorectal cancer: A comparative study for PFS and OS of the WT and MT KRAS colorectal cancer patients has been done with antibody therapy (panitumumab, cetuximab and bevacizumab) alone along with the combination of antibody and chemotherapy (FOLFOX-4).